MERTK and rheumatoid arthritis: In addition to the evaluation of surface M2 markers, the capability of CTLA4-Ig treatment to induce the upregulation of the gene expression of MerTK, a functional M2 marker relevant in RA pathogenesis, was also investigated in cultured RA-MDMs.